Home > Back to Publisher > Report Information
European Markets for Orthopedic Biomaterials 2009iData Research, Inc.April 1, 2009 545 Pages - SKU: IDR2274604 |
| Currently available at a discount of 25% off the full price due to age In 2008, the combined European biomaterial market was worth €271.4 million. This includes hyaluronic acid viscosupplements, bone graft substitutes, BMP growth factors, autologous chondrocyte implantation and platelet/bone marrow concentration systems. Within this report, the various bone grafting materials are examined, including autografted bone, allografts, demineralized bone and synthetic bone substitutes. The market across Europe is highly dependant on regulation, reimbursement and regional supply issues. Each of these has shaped the products of preference in each country, and understanding how they interact is a vital importance in providing orthopedic biomaterials to the European market. The European market encompasses Germany, France, Italy, United Kingdom (U.K.), Spain, Benelux (Belgium, the Netherlands, and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Switzerland, Austria, and Portugal. |
- EXECUTIVE SUMMARY
- 1.1 TOTAL EUROPEAN ORTHOPEDIC BIOMATERIAL MARKET
- 1.2 AUTOGRAFTED BONE PROCEDURES
- 1.3 BONE GRAFT SUBSTITUTE WASTAGE
- 1.4 ALLOGRAFT, DBM AND SYNTHETIC BONE GRAFT SUBSTITUTE MARKET
- 1.5 HYALURONIC VISCOSUPPLEMENT MARKET
- 1.6 AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET
- 1.7 BMP GROWTH FACTOR MARKET
- 1.8 PLATELET AND BONE MARROW CONCENTRATION MARKET
- 1.9 LEADING COMPETITORS
- RESEARCH METHODOLOGY
- 2.1 RESEARCH SCOPE
- 2.2 IDATA’S 9-STEP METHODOLOGY
- Step 1: Project Initiation & Team Selection
- Step 2: Prepare Data Systems and Perform Secondary Research
- Step 3: Preparation for Interviews & Survey Design
- Step 4: Performing Primary Research
- Step 5: Research Analysis: Establishing Baseline Estimates
- Step 6: Market Forecasting
- Step 7: Identify Strategic Opportunities
- Step 8: Final Review and Market Release
- Step 9: Customer Feedback and Market Monitoring
- OVERVIEW OF EUROPEAN ORTHOPEDIC BIOMATERIALS
- 3.1 INTRODUCTION
- 3.2 OVERVIEW
- 3.2.1 Growth Factors
- 3.2.2 Bone Graft Substitutes
- 3.2.3 Hyaluronic Acid Viscosupplementation
- 3.2.4 Autologous Chondrocyte Implantation (ACI)
- 3.2.5 Platelet and Bone Marrow Concentration
- 3.3 CURRENCY EXCHANGE RATE
- 3.4 MARKET ANALYSIS AND FORECAST
- 3.4.1 Analysis and Forecast of Total Market
- 3.5 MARKET DRIVERS
- 3.6 MARKET LIMITERS
- 3.7 COMPETITIVE ANALYSIS
- 3.7.1 Leading Competitors
- 3.7.2 Market Concentration
- 3.8 MERGERS AND ACQUISITIONS
- COUNTRY PROFILES
- 4.1 INTRODUCTION
- 4.1.1 Population
- 4.1.2 GDP per Capita
- 4.1.3 Procedures
- 4.1.4 Price Index
- 4.1.5 Germany
- 4.2 FRANCE
- 4.3 UNITED KINGDOM
- 4.4 SPAIN
- 4.5 ITALY
- 4.6 BENELUX
- 4.7 SCANDINAVIA
- 4.8 SWITZERLAND
- 4.9 AUSTRIA
- 4.10 PORTUGAL
- 4.11 GREECE
- BONE GRAFT SUBSTITUTE MARKET
- 5.1 TOTAL MARKET
- 5.1.1 Introduction
- 5.1.2 Overview
- 5.1.3 Volume Usage and Pricing
- 5.1.3.1 Wastage
- 5.1.3.2 Volumes Represented per Procedure
- 5.1.4 Autograft Procedures
- 5.1.5 Spine Fusion Procedures
- 5.1.6 Market Analysis and Forecast
- 5.1.6.1 Total Commercial Bone Graft Substitute Market
- 5.1.6.2 Total Utilized Bone Graft Substitute Market
- 5.1.6.3 Total Spine Market by Allograft, DBM and Synthetic Materials
- 5.1.6.4 Cervical Spine Market by Allograft, DBM and Synthetic Materials
- 5.1.6.5 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
- 5.1.6.6 Extremity Market by Allograft, DBM and Synthetic Materials
- 5.1.6.7 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
- 5.1.7 Market Drivers and Limiters
- 5.1.7.1 Market Drivers
- 5.1.7.2 Market Limiters
- 5.1.8 Competitive Analysis
- 5.1.8.1 Bone Graft Substitute Market
- 5.1.8.2 Spinal Fusion Market Leading Competitors
- 5.2 GERMANY
- 5.2.1 Autograft Procedures
- 5.2.2 Spine Fusion Procedures
- 5.2.3 Market Forecast and Analysis
- 5.2.3.1 Total Commercial Bone Graft Substitute Market
- 5.2.3.2 Total Utilized Bone Graft Substitute Market
- 5.2.3.3 Total Market by Allograft, DBM and Synthetic Materials
- 5.2.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
- 5.2.3.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
- 5.2.3.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
- 5.2.3.7 Extremity Market by Allograft, DBM and Synthetic Materials
- 5.2.3.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
- 5.2.4 Market Drivers and Limiters
- 5.2.4.1 Market Drivers
- 5.2.4.2 Market Limiters
- 5.2.5 France
- 5.2.6 Autograft Procedures
- 5.2.7 Spine Fusion Procedures
- 5.2.8 Market Forecast and Analysis
- 5.2.8.1 Total Commercial Bone Graft Substitute Market
- 5.2.8.2 Total Utilized Bone Graft Substitute Market
- 5.2.8.3 Total Market by Allograft, DBM and Synthetic Materials
- 5.2.8.4 Total Spine Market by Allograft, DBM and Synthetic Materials
- 5.2.8.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
- 5.2.8.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
- 5.2.8.7 Extremity Market by Allograft, DBM and Synthetic Materials
- 5.2.8.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
- 5.2.9 Market Drivers and Limiters
- 5.2.9.1 Market Drivers
- 5.2.9.2 Market Limiters
- 5.3 UNITED KINGDOM
- 5.3.1 Autograft Procedures
- 5.3.2 Spine Fusion Procedures
- 5.3.3 Market Forecast and Analysis
- 5.3.3.1 Total Commercial Bone Graft Substitute Market
- 5.3.3.2 Total Utilized Bone Graft Substitute Market
- 5.3.3.3 Total Market by Allograft, DBM and Synthetic Materials
- 5.3.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
- 5.3.3.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
- 5.3.3.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
- 5.3.3.7 Extremity Market by Allograft, DBM and Synthetic Materials
- 5.3.3.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
- 5.3.4 Market Drivers and Limiters
- 5.3.4.1 Market Drivers
- 5.3.4.2 Market Limiters
- 5.4 SPAIN
- 5.4.1 Autograft Procedures
- 5.4.2 Spine Fusion Procedures
- 5.4.3 Market Forecast and Analysis
- 5.4.3.1 Total Commercial Bone Graft Substitute Market
- 5.4.3.2 Total Utilized Bone Graft Substitute Market
- 5.4.3.3 Total Market by Allograft, DBM and Synthetic Materials
- 5.4.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
- 5.4.3.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
- 5.4.3.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
- 5.4.3.7 Extremity Market by Allograft, DBM and Synthetic Materials
- 5.4.3.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
- 5.4.4 Market Drivers and Limiters
- 5.4.4.1 Market Drivers
- 5.4.4.2 Market Limiters
- 5.5 ITALY
- 5.5.1 Autograft Procedures
- 5.5.2 Spine Fusion Procedures
- 5.5.3 Market Forecast and Analysis
- 5.5.3.1 Total Commercial Bone Graft Substitute Market
- 5.5.3.2 Total Utilized Bone Graft Substitute Market
- 5.5.3.3 Total Market by Allograft, DBM and Synthetic Materials
- 5.5.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
- 5.5.3.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
- 5.5.3.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
- 5.5.3.7 Extremity Market by Allograft, DBM and Synthetic Materials
- 5.5.3.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
- 5.5.4 Market Drivers and Limiters
- 5.5.4.1 Market Drivers
- 5.5.4.2 Market Limiters
- 5.6 BENELUX
- 5.6.1 Autograft Procedures
- 5.6.2 Spine Fusion Procedures
- 5.6.3 Market Forecast and Analysis
- 5.6.3.1 Total Commercial Bone Graft Substitute Market
- 5.6.3.2 Total Utilized Bone Graft Substitute Market
- 5.6.3.3 Total Market by Allograft, DBM and Synthetic Materials
- 5.6.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
- 5.6.3.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
- 5.6.3.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
- 5.6.3.7 Extremity Market by Allograft, DBM and Synthetic Materials
- 5.6.3.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
- 5.6.4 Market Drivers and Limiters
- 5.6.4.1 Market Drivers
- 5.6.4.2 Market Limiters
- 5.7 SCANDINAVIA
- 5.7.1 Autograft Procedures
- 5.7.2 Spine Fusion Procedures
- 5.7.3 Market Forecast and Analysis
- 5.7.3.1 Total Commercial Bone Graft Substitute Market
- 5.7.3.2 Total Utilized Bone Graft Substitute Market
- 5.7.3.3 Total Market by Allograft, DBM and Synthetic Materials
- 5.7.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
- 5.7.3.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
- 5.7.3.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
- 5.7.3.7 Extremity Market by Allograft, DBM and Synthetic Materials
- 5.7.3.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
- 5.7.4 Market Drivers and Limiters
- 5.7.4.1 Market Drivers
- 5.7.4.2 Market Limiters
- 5.8 SWITZERLAND
- 5.8.1 Autograft Procedures
- 5.8.2 Spine Fusion Procedures
- 5.8.3 Market Forecast and Analysis
- 5.8.3.1 Total Commercial Bone Graft Substitute Market
- 5.8.3.2 Total Utilized Bone Graft Substitute Market
- 5.8.3.3 Total Market by Allograft, DBM and Synthetic Materials
- 5.8.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
- 5.8.3.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
- 5.8.3.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
- 5.8.3.7 Extremity Market by Allograft, DBM and Synthetic Materials
- 5.8.3.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
- 5.8.4 Market Drivers and Limiters
- 5.8.4.1 Market Drivers
- 5.8.4.2 Market Limiters
- 5.9 AUSTRIA
- 5.9.1 Autograft Procedures
- 5.9.2 Spine Fusion Procedures
- 5.9.3 Market Forecast and Analysis
- 5.9.3.1 Total Commercial Bone Graft Substitute Market
- 5.9.3.2 Total Utilized Bone Graft Substitute Market
- 5.9.3.3 Total Market by Allograft, DBM and Synthetic Materials
- 5.9.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
- 5.9.3.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
- 5.9.3.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
- 5.9.3.7 Extremity Market by Allograft, DBM and Synthetic Materials
- 5.9.3.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
- 5.9.4 Market Drivers and Limiters
- 5.9.4.1 Market Drivers
- 5.9.4.2 Market Limiters
- 5.10 PORTUGAL
- 5.10.1 Autograft Procedures
- 5.10.2 Spine Fusion Procedures
- 5.10.3 Market Forecast and Analysis
- 5.10.3.1 Total Commercial Bone Graft Substitute Market
- 5.10.3.2 Total Utilized Bone Graft Substitute Market
- 5.10.3.3 Total Market by Allograft, DBM and Synthetic Materials
- 5.10.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
- 5.10.3.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
- 5.10.3.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials 400
- 5.10.3.7 Extremity Market by Allograft, DBM and Synthetic Materials
- 5.10.3.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
- 5.10.4 Market Drivers and Limiters
- 5.10.4.1 Market Drivers
- 5.10.4.2 Market Limiters
- 5.11 GREECE
- 5.11.1 Autograft Procedures
- 5.11.2 Spine Fusion Procedures
- 5.11.3 Market Forecast and Analysis
- 5.11.3.1 Total Commercial Bone Graft Substitute Market
- 5.11.3.2 Total Utilized Bone Graft Substitute Market
- 5.11.3.3 Total Market by Allograft, DBM and Synthetic Materials
- 5.11.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
- 5.11.3.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
- 5.11.3.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials 432
- 5.11.3.7 Extremity Market by Allograft, DBM and Synthetic Materials
- 5.11.3.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
- 5.11.4 Market Drivers and Limiters
- 5.11.4.1 Market Drivers
- 5.11.4.2 Market Limiters
- BMP GROWTH FACTOR MARKET
- 6.1 INTRODUCTION
- 6.1.1 Overview
- 6.1.2 Potential Complications
- 6.1.3 Future Indications
- 6.2 MARKET ANALYSIS AND FORECAST
- 6.3 MARKET DRIVERS AND LIMITERS
- 6.3.1.1 Market Drivers
- 6.3.1.2 Market Limiters
- 6.4 COMPETITIVE ANALYSIS
- HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
- 7.1 INTRODUCTION
- 7.1.1 Three-Injection Cycle Products
- 7.1.2 Five-Injection Cycle Products
- 7.1.3 Single-Injection Cycle Products
- 7.2 MARKET ANALYSIS AND FORECAST
- 7.2.1 Total Market
- 7.2.2 Single-Cycle
- 7.2.3 Three-Cycle
- 7.2.4 Five-Cycle
- 7.2.5 Hyaluronic Acid Viscosupplementation Injections per Country
- 7.3 MARKET DRIVERS AND LIMITERS
- 7.3.1 Market Drivers
- 7.3.2 Market Limiters
- 7.4 COMPETITIVE ANALYSIS
- AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET
- 8.1 INTRODUCTION
- 8.2 OVERVIEW
- 8.3 MARKET FORECAST AND ANALYSIS
- 8.4 MARKET DRIVERS AND LIMITERS
- 8.4.1.1 Market Drivers
- 8.4.1.2 Market Limiters
- 8.5 COMPETITIVE ANALYSIS
- PLATELET AND BONE MARROW CONCENTRATION MARKET
- 9.1 INTRODUCTION
- 9.2 OVERVIEW
- 9.2.1 Platelet Rich Plasma
- 9.2.2 Bone Marrow Aspirate
- 9.3 MARKET ANALYSIS AND FORECAST
- 9.3.1.1 Total Cell Concentration Market
- 9.3.1.2 Platelet Concentration
- 9.3.1.3 Bone Marrow Concentration
- 9.4 MARKET DRIVERS AND LIMITERS
- 9.4.1.1 Market Drivers
- 9.4.1.2 Market Limiters
- 9.5 COMPETITIVE ANALYSIS
- ABBREVIATIONS
- APPENDIX 1: JOINT RECONSTRUCTION PROCEDURES
- LIST OF FIGURES
- EXECUTIVE SUMMARY
- RESEARCH METHODOLOGY
- OVERVIEW OF EUROPEAN ORTHOPEDIC BIOMATERIALS
- Figure 3-1: Exchange Rate Between Euro and Other Currencies, 2008
- Figure 3-2: Total European Orthopedic Biomaterial Market, Europe, 2005 - 2015 (€)
- Figure 3-3: Total European Orthopedic Biomaterial Market, Europe, 2005 - 2015 (US$)
- Figure 3-4: Market Drivers, Orthopedic Biomaterials Market, Europe, 2008
- Figure 3-5: Market Limiters, Orthopedic Biomaterials Market, Europe, 2008
- Figure 3-6: Leading Competitors, Orthopedic Biomaterials Market, Europe, 2008 30
- Figure 3-7: Other Notable Competitors, Orthopedic Biomaterial Market, Europe, 2008
- Figure 3-8 Market Concentration, Orthopedic Biomaterials Market, U.S., 2007
- COUNTRY PROFILES
- BONE GRAFT SUBSTITUTE MARKET
- Figure 5-1: Total Autograft Procedures, Europe, 2005 - 2015
- Figure 5-2 Spine Fusion Procedures, Europe, 2005 - 2015
- Figure 5-3: Total Bone Graft Substitute Market, Europe, 2005 - 2015 (€)
- Figure 5-4: Total Bone Graft Substitute Market, Europe, 2005 - 2015 (US$)
- Figure 5-5 Total Procedures by Indication, Europe, 2005 - 2015
- Figure 5-6 Total Utilized Market Value by Indication, Europe, 2005 - 2015 (€)
- Figure 5-7 Total Utilized Market Value by Indication, Europe, 2005 - 2015 (US$)
- Figure 5-8: Utilized Bone Graft Substitute Market, Europe, 2005 - 2015 (€)
- Figure 5-9: Utilized Bone Graft Substitute Market, Europe, 2005 - 2015 (US$)
- Figure 5-10: Total Allograft Market, Europe, 2005 - 2015 (€)
- Figure 5-11: Total Allograft Market, Europe, 2005 - 2015 (US$)
- Figure 5-12: Total DBM Market, Europe, 2005 - 2015 (€)
- Figure 5-13: Total DBM Market, Europe, 2005 - 2015 (US$)
- Figure 5-14: Total Synthetic Market, Europe, 2005 - 2015 (€)
- Figure 5-15: Total Synthetic Market, Europe, 2005 - 2015 (US$)
- Figure 5-16: Allograft Spine Market, Europe, 2005 - 2015 (€)
- Figure 5-17: Allograft Spine Market, Europe, 2005 - 2015 (US$)
- Figure 5-18: DBM Spine Market, Europe, 2005 - 2015 (€)
- Figure 5-19: DBM Spine Market, Europe, 2005 - 2015 (US$)
- Figure 5-20: Synthetic Spine Market, Europe, 2005 - 2015 (€)
- Figure 5-21: Synthetic Spine Market, Europe, 2005 - 2015 (US$)
- Figure 5-22: Allograft Cervical Spine Market, Europe, 2005 - 2015 (€)
- Figure 5-23: Allograft Cervical Spine Market, Europe, 2005 - 2015 (US$)
- Figure 5-24: DBM Cervical Spine Market, Europe, 2005 - 2015 (€)
- Figure 5-25: DBM Cervical Spine Market, Europe, 2005 - 2015 (US$)
- Figure 5-26: Synthetic Cervical Spine Market, Europe, 2005 - 2015 (€)
- Figure 5-27: Synthetic Cervical Spine Market, Europe, 2005 - 2015 (US$)
- Figure 5-28: Allograft Thoracolumbar Spine Market, Europe, 2005 - 2015 (€)
- Figure 5-29: Allograft Thoracolumbar Spine Market, Europe, 2005 - 2015 (US$) 74
- Figure 5-30: DBM Thoracolumbar Spine Market, Europe, 2005 - 2015 (€)
- Figure 5-31: DBM Thoracolumbar Spine Market, Europe, 2005 - 2015 (US$)
- Figure 5-32: Synthetic Thoracolumbar Spine Market, Europe, 2005 - 2015 (€)
- Figure 5-33: Synthetic Thoracolumbar Spine Market, Europe, 2005 - 2015 (US$)76
- Figure 5-34: Allograft Extremity Market, Europe, 2005 - 2015 (€)
- Figure 5-35: Allograft Extremity Market, Europe, 2005 - 2015 (US$)
- Figure 5-36: DBM Extremity Market, Europe, 2005 - 2015 (€)
- Figure 5-37: DBM Extremity Market, Europe, 2005 - 2015 (US$)
- Figure 5-38: Synthetic Extremity Market, Europe, 2005 - 2015 (€)
- Figure 5-39: Synthetic Extremity Market, Europe, 2005 - 2015 (US$)
- Figure 5-40: Allograft CMF Market, Europe, 2005 - 2015 (€)
- Figure 5-41: Allograft CMF Market, Europe, 2005 - 2015 (US$)
- Figure 5-42: DBM CMF Market, Europe, 2005 - 2015 (€)
- Figure 5-43: DBM CMF Market, Europe, 2005 - 2015 (US$)
- Figure 5-44: Synthetic CMF Market, Europe, 2005 - 2015 (€)
- Figure 5-45: Synthetic CMF Market, Europe, 2005 - 2015 (US$)
- Figure 5-46: Market Drivers and Limiters, Bone Graft Substitute Market, Europe, 2005 - 2015
- Figure 5-47: Leading Competitors, Bone Graft Substitute Market, Europe, 2008
- Figure 5-48: Leading Competitors in Spinal Fusion Market, Europe, 2008
- Figure 5-49: Total Autograft Procedures, Germany, 2005 - 2015
- Figure 5-50 Spine Fusion Procedures, Germany, 2005 - 2015
- Figure 5-51: Total Bone Graft Substitute Market, Germany, 2005 - 2015 (€)
- Figure 5-52: Total Bone Graft Substitute Market, Germany, 2005 - 2015 (US$)
- Figure 5-53 Total Procedures by Indication, Germany, 2005 - 2015
- Figure 5-54 Total Utilized Market Value by Indication, Germany, 2005 - 2015 (€)
- Figure 5-55 Total Utilized Market Value by Indication, Germany, 2005 - 2015 (US$)
- Figure 5-56: Utilized Bone Graft Substitute Market, Germany, 2005 - 2015 (€)
- Figure 5-57: Utilized Bone Graft Substitute Market, Germany, 2005 - 2015 (US$)
- Figure 5-58: Total Allograft Market, Germany, 2005 - 2015 (€)
- Figure 5-59: Total Allograft Market, Germany, 2005 - 2015 (US$)
- Figure 5-60: Total DBM Market, Germany, 2005 - 2015 (€)
- Figure 5-61: Total DBM Market, Germany, 2005 - 2015 (US$)
- Figure 5-62: Total Synthetic Market, Germany, 2005 - 2015 (€)
- Figure 5-63: Total Synthetic Market, Germany, 2005 - 2015 (US$)
- Figure 5-64: Allograft Spine Market, Germany, 2005 - 2015 (€)
- Figure 5-65: Allograft Spine Market, Germany, 2005 - 2015 (US$)
- Figure 5-66: DBM Spine Market, Germany, 2005 - 2015 (€)
- Figure 5-67: DBM Spine Market, Germany, 2005 - 2015 (US$)
- Figure 5-68: Synthetic Spine Market, Germany, 2005 - 2015 (€)
- Figure 5-69: Synthetic Spine Market, Germany, 2005 - 2015 (US$)
- Figure 5-70: Allograft Cervical Spine Market, Germany, 2005 - 2015 (€)
- Figure 5-71: Allograft Cervical Spine Market, Germany, 2005 - 2015 (US$)
- Figure 5-72: DBM Cervical Spine Market, Germany, 2005 - 2015 (€)
- Figure 5-73: DBM Cervical Spine Market, Germany, 2005 - 2015 (US$)
- Figure 5-74: Synthetic Cervical Spine Market, Germany, 2005 - 2015 (€)
- Figure 5-75: Synthetic Cervical Spine Market, Germany, 2005 - 2015 (US$)
- Figure 5-76: Allograft Thoracolumbar Spine Market, Germany, 2005 - 2015 (€) 112
- Figure 5-77: Allograft Thoracolumbar Spine Market, Germany, 2005 - 2015 (US$)
- Figure 5-78: DBM Thoracolumbar Spine Market, Germany, 2005 - 2015 (€)
- Figure 5-79: DBM Thoracolumbar Spine Market, Germany, 2005 - 2015 (US$) 113
- Figure 5-80: Synthetic Thoracolumbar Spine Market, Germany, 2005 - 2015 (€)114
- Figure 5-81: Synthetic Thoracolumbar Spine Market, Germany, 2005 - 2015 (US$)
- Figure 5-82: Allograft Extremity Market, Germany, 2005 - 2015 (€)
- Figure 5-83: Allograft Extremity Market, Germany, 2005 - 2015 (US$)
- Figure 5-84: DBM Extremity Market, Germany, 2005 - 2015 (€)
- Figure 5-85: DBM Extremity Market, Germany, 2005 - 2015 (US$)
- Figure 5-86: Synthetic Extremity Market, Germany, 2005 - 2015 (€)
- Figure 5-87: Synthetic Extremity Market, Germany, 2005 - 2015 (US$)
- Figure 5-88: Allograft CMF Market, Germany, 2005 - 2015 (€)
- Figure 5-89: Allograft CMF Market, Germany, 2005 - 2015 (US$)
- Figure 5-90: DBM CMF Market, Germany, 2005 - 2015 (€)
- Figure 5-91: DBM CMF Market, Germany, 2005 - 2015 (US$)
- Figure 5-92: Synthetic CMF Market, Germany, 2005 - 2015 (€)
- Figure 5-93: Synthetic CMF Market, Germany, 2005 - 2015 (US$)
- Figure 5-94: Market Drivers and Limiters, Germany, Bone Graft Substitute Market, 2005 - 2015
- Figure 5-95: Total Autograft Procedures, France, 2005 - 2015
- Figure 5-96 Spine Fusion Procedures, France, 2005 - 2015
- Figure 5-97: Total Bone Graft Substitute Market, France, 2005 - 2015 (€)
- Figure 5-98: Total Bone Graft Substitute Market, France, 2005 - 2015 (US$)
- Figure 5-99 Total Procedures by Indication, France, 2005 - 2015
- Figure 5-100 Total Utilized Market Value by Indication, France, 2005 - 2015 (€)129
- Figure 5-101 Total Utilized Market Value by Indication, France, 2005 - 2015 (US$)
- Figure 5-102: Utilized Bone Graft Substitute Market, France, 2005 - 2015 (€)
- Figure 5-103: Utilized Bone Graft Substitute Market, France, 2005 - 2015 (US$)130
- Figure 5-104: Total Allograft Market, France, 2005 - 2015 (€)
- Figure 5-105: Total Allograft Market, France, 2005 - 2015 (US$)
- Figure 5-106: Total DBM Market, France, 2005 - 2015 (€)
- Figure 5-107: Total DBM Market, France, 2005 - 2015 (US$)
- Figure 5-108: Total Synthetic Market, France, 2005 - 2015 (€)
- Figure 5-109: Total Synthetic Market, France, 2005 - 2015 (US$)
- Figure 5-110: Allograft Spine Market, France, 2005 - 2015 (€)
- Figure 5-111: Allograft Spine Market, France, 2005 - 2015 (US$)
- Figure 5-112: DBM Spine Market, France, 2005 - 2015 (€)
- Figure 5-113: DBM Spine Market, France, 2005 - 2015 (US$)
- Figure 5-114: Synthetic Spine Market, France, 2005 - 2015 (€)
- Figure 5-115: Synthetic Spine Market, France, 2005 - 2015 (US$)
- Figure 5-116: Allograft Cervical Spine Market, France, 2005 - 2015 (€)
- Figure 5-117: Allograft Cervical Spine Market, France, 2005 - 2015 (US$)
- Figure 5-118: DBM Cervical Spine Market, France, 2005 - 2015 (€)
- Figure 5-119: DBM Cervical Spine Market, France, 2005 - 2015 (US$)
- Figure 5-120: Synthetic Cervical Spine Market, France, 2005 - 2015 (€)
- Figure 5-121: Synthetic Cervical Spine Market, France, 2005 - 2015 (US$)
- Figure 5-122: Allograft Thoracolumbar Spine Market, France, 2005 - 2015 (€) . 144
- Figure 5-123: Allograft Thoracolumbar Spine Market, France, 2005 - 2015 (US$)144
- Figure 5-124: DBM Thoracolumbar Spine Market, France, 2005 - 2015 (€)
- Figure 5-125: DBM Thoracolumbar Spine Market, France, 2005 - 2015 (US$)
- Figure 5-126: Synthetic Thoracolumbar Spine Market, France, 2005 - 2015 (€) 146
- Figure 5-127: Synthetic Thoracolumbar Spine Market, France, 2005 - 2015 (US$)
- Figure 5-128: Allograft Extremity Market, France, 2005 - 2015 (€)
- Figure 5-129: Allograft Extremity Market, France, 2005 - 2015 (US$)
- Figure 5-130: DBM Extremity Market, France, 2005 - 2015 (€)
- Figure 5-131: DBM Extremity Market, France, 2005 - 2015 (US$)
- Figure 5-132: Synthetic Extremity Market, France, 2005 - 2015 (€)
- Figure 5-133: Synthetic Extremity Market, France, 2005 - 2015 (US$)
- Figure 5-134: Allograft CMF Market, France, 2005 - 2015 (€)
- Figure 5-135: Allograft CMF Market, France, 2005 - 2015 (US$)
- Figure 5-136: DBM CMF Market, France, 2005 - 2015 (€)
- Figure 5-137: DBM CMF Market, France, 2005 - 2015 (US$)
- Figure 5-138: Synthetic CMF Market, France, 2005 - 2015 (€)
- Figure 5-139: Synthetic CMF Market, France, 2005 - 2015 (US$)
- Figure 5-140: Market Drivers and Limiters, France, Bone Graft Substitute Market, 2005 - 2015
- Figure 5-141: Total Autograft Procedures, U.K., 2005 - 2015
- Figure 5-142 Spine Fusion Procedures, U.K., 2005 - 2015
- Figure 5-143: Total Bone Graft Substitute Market, U.K., 2005 - 2015 (€)
- Figure 5-144: Total Bone Graft Substitute Market, U.K., 2005 - 2015 (US$)
- Figure 5-145 Total Procedures by Indication, U.K., 2005 - 2015
- Figure 5-146 Total Utilized Market Value by Indication, U.K., 2005 - 2015 (€) 161
- Figure 5-147 Total Utilized Market Value by Indication, U.K., 2005 - 2015 (US$)
- Figure 5-148: Utilized Bone Graft Substitute Market, U.K., 2005 - 2015 (€)
- Figure 5-149: Utilized Bone Graft Substitute Market, U.K., 2005 - 2015 (US$) 162
- Figure 5-150: Total Allograft Market, U.K., 2005 - 2015 (€)
- Figure 5-151: Total Allograft Market, U.K., 2005 - 2015 (US$)
- Figure 5-152: Total DBM Market, U.K., 2005 - 2015 (€)
- Figure 5-153: Total DBM Market, U.K., 2005 - 2015 (US$)
- Figure 5-154: Total Synthetic Market, U.K., 2005 - 2015 (€)
- Figure 5-155: Total Synthetic Market, U.K., 2005 - 2015 (US$)
- Figure 5-156: Allograft Spine Market, U.K., 2005 - 2015 (€)
- Figure 5-157: Allograft Spine Market, U.K., 2005 - 2015 (US$)
- Figure 5-158: DBM Spine Market, U.K., 2005 - 2015 (€)
- Figure 5-159: DBM Spine Market, U.K., 2005 - 2015 (US$)
- Figure 5-160: Synthetic Spine Market, U.K., 2005 - 2015 (€)
- Figure 5-161: Synthetic Spine Market, U.K., 2005 - 2015 (US$)
- Figure 5-162: Allograft Cervical Spine Market, U.K., 2005 - 2015 (€)
- Figure 5-163: Allograft Cervical Spine Market, U.K., 2005 - 2015 (US$)
- Figure 5-164: DBM Cervical Spine Market, U.K., 2005 - 2015 (€)
- Figure 5-165: DBM Cervical Spine Market, U.K., 2005 - 2015 (US$)
- Figure 5-166: Synthetic Cervical Spine Market, U.K., 2005 - 2015 (€)
- Figure 5-167: Synthetic Cervical Spine Market, U.K., 2005 - 2015 (US$)
- Figure 5-168: Allograft Thoracolumbar Spine Market, U.K., 2005 - 2015 (€)
- Figure 5-169: Allograft Thoracolumbar Spine Market, U.K., 2005 - 2015 (US$) 176
- Figure 5-170: DBM Thoracolumbar Spine Market, U.K., 2005 - 2015 (€)
- Figure 5-171: DBM Thoracolumbar Spine Market, U.K., 2005 - 2015 (US$)
- Figure 5-172: Synthetic Thoracolumbar Spine Market, U.K., 2005 - 2015 (€)
- Figure 5-173: Synthetic Thoracolumbar Spine Market, U.K., 2005 - 2015 (US$)178
- Figure 5-174: Allograft Extremity Market, U.K., 2005 - 2015 (€)
- Figure 5-175: Allograft Extremity Market, U.K., 2005 - 2015 (US$)
- Figure 5-176: DBM Extremity Market, U.K., 2005 - 2015 (€)
- Figure 5-177: DBM Extremity Market, U.K., 2005 - 2015 (US$)
- Figure 5-178: Synthetic Extremity Market, U.K., 2005 - 2015 (€)
- Figure 5-179: Synthetic Extremity Market, U.K., 2005 - 2015 (US$)
- Figure 5-180: Allograft CMF Market, U.K., 2005 - 2015 (€)
- Figure 5-181: Allograft CMF Market, U.K., 2005 - 2015 (US$)
- Figure 5-182: DBM CMF Market, U.K., 2005 - 2015 (€)
- Figure 5-183: DBM CMF Market, U.K., 2005 - 2015 (US$)
- Figure 5-184: Synthetic CMF Market, U.K., 2005 - 2015 (€)
- Figure 5-185: Synthetic CMF Market, U.K., 2005 - 2015 (US$)
- Figure 5-186: Market Drivers and Limiters, U.K., Bone Graft Substitute Market, 2005 - 2015
- Figure 5-187: Total Autograft Procedures, Spain, 2005 - 2015
- Figure 5-188 Spine Fusion Procedures, Spain, 2005 - 2015
- Figure 5-189: Total Bone Graft Substitute Market, Spain, 2005 - 2015 (€)
- Figure 5-190: Total Bone Graft Substitute Market, Spain, 2005 - 2015 (US$)
- Figure 5-191 Total Procedures by Indication, Spain, 2005 - 2015
- Figure 5-192 Total Utilized Market Value by Indication, Spain, 2005 - 2015 (€)193
- Figure 5-193 Total Utilized Market Value by Indication, Spain, 2005 - 2015 (US$)
- Figure 5-194: Utilized Bone Graft Substitute Market, Spain, 2005 - 2015 (€)
- Figure 5-195: Utilized Bone Graft Substitute Market, Spain, 2005 - 2015 (US$) 194
- Figure 5-196: Total Allograft Market, Spain, 2005 - 2015 (€)
- Figure 5-197: Total Allograft Market, Spain, 2005 - 2015 (US$)
- Figure 5-198: Total DBM Market, Spain, 2005 - 2015 (€)
- Figure 5-199: Total DBM Market, Spain, 2005 - 2015 (US$)
- Figure 5-200: Total Synthetic Market, Spain, 2005 - 2015 (€)
- Figure 5-201: Total Synthetic Market, Spain, 2005 - 2015 (US$)
- Figure 5-202: Allograft Spine Market, Spain, 2005 - 2015 (€)
- Figure 5-203: Allograft Spine Market, Spain, 2005 - 2015 (US$)
- Figure 5-204: DBM Spine Market, Spain, 2005 - 2015 (€)
- Figure 5-205: DBM Spine Market, Spain, 2005 - 2015 (US$)
- Figure 5-206: Synthetic Spine Market, Spain, 2005 - 2015 (€)
- Figure 5-207: Synthetic Spine Market, Spain, 2005 - 2015 (US$)
- Figure 5-208: Allograft Cervical Spine Market, Spain, 2005 - 2015 (€)
- Figure 5-209: Allograft Cervical Spine Market, Spain, 2005 - 2015 (US$)
- Figure 5-210: DBM Cervical Spine Market, Spain, 2005 - 2015 (€)
- Figure 5-211: DBM Cervical Spine Market, Spain, 2005 - 2015 (US$)
- Figure 5-212: Synthetic Cervical Spine Market, Spain, 2005 - 2015 (€)
- Figure 5-213: Synthetic Cervical Spine Market, Spain, 2005 - 2015 (US$)
- Figure 5-214: Allograft Thoracolumbar Spine Market, Spain, 2005 - 2015 (€)
- Figure 5-215: Allograft Thoracolumbar Spine Market, Spain, 2005 - 2015 (US$)208
- Figure 5-216: DBM Thoracolumbar Spine Market, Spain, 2005 - 2015 (€)
- Figure 5-217: DBM Thoracolumbar Spine Market, Spain, 2005 - 2015 (US$)
- Figure 5-218: Synthetic Thoracolumbar Spine Market, Spain, 2005 - 2015 (€)
- Figure 5-219: Synthetic Thoracolumbar Spine Market, Spain, 2005 - 2015 (US$)210
- Figure 5-220: Allograft Extremity Market, Spain, 2005 - 2015 (€)
- Figure 5-221: Allograft Extremity Market, Spain, 2005 - 2015 (US$)
- Figure 5-222: DBM Extremity Market, Spain, 2005 - 2015 (€)
- Figure 5-223: DBM Extremity Market, Spain, 2005 - 2015 (US$)
- Figure 5-224: Synthetic Extremity Market, Spain, 2005 - 2015 (€)
- Figure 5-225: Synthetic Extremity Market, Spain, 2005 - 2015 (US$)
- Figure 5-226: Allograft CMF Market, Spain, 2005 - 2015 (€)
- Figure 5-227: Allograft CMF Market, Spain, 2005 - 2015 (US$)
- Figure 5-228: DBM CMF Market, Spain, 2005 - 2015 (€)
- Figure 5-229: DBM CMF Market, Spain, 2005 - 2015 (US$)
- Figure 5-230: Synthetic CMF Market, Spain, 2005 - 2015 (€)
- Figure 5-231: Synthetic CMF Market, Spain, 2005 - 2015 (US$)
- Figure 5-232: Market Drivers and Limiters, Spain, Bone Graft Substitute Market, 2005 - 2015
- Figure 5-233: Total Autograft Procedures, Italy, 2005 - 2015
- Figure 5-234 Spine Fusion Procedures, Italy, 2005 - 2015
- Figure 5-235: Total Bone Graft Substitute Market, Italy, 2005 - 2015 (€)
- Figure 5-236: Total Bone Graft Substitute Market, Italy, 2005 - 2015 (US$)
- Figure 5-237 Total Procedures by Indication, Italy, 2005 - 2015
- Figure 5-238 Total Utilized Market Value by Indication, Italy, 2005 - 2015 (€) 225
- Figure 5-239 Total Utilized Market Value by Indication, Italy, 2005 - 2015 (US$)
- Figure 5-240: Utilized Bone Graft Substitute Market, Italy, 2005 - 2015 (€)
- Figure 5-241: Utilized Bone Graft Substitute Market, Italy, 2005 - 2015 (US$). 226
- Figure 5-242: Total Allograft Market, Italy, 2005 - 2015 (€)
- Figure 5-243: Total Allograft Market, Italy, 2005 - 2015 (US$)
- Figure 5-244: Total DBM Market, Italy, 2005 - 2015 (€)
- Figure 5-245: Total DBM Market, Italy, 2005 - 2015 (US$)
- Figure 5-246: Total Synthetic Market, Italy, 2005 - 2015 (€)
- Figure 5-247: Total Synthetic Market, Italy, 2005 - 2015 (US$)
- Figure 5-248: Allograft Spine Market, Italy, 2005 - 2015 (€)
- Figure 5-249: Allograft Spine Market, Italy, 2005 - 2015 (US$)
- Figure 5-250: DBM Spine Market, Italy, 2005 - 2015 (€)
- Figure 5-251: DBM Spine Market, Italy, 2005 - 2015 (US$)
- Figure 5-252: Synthetic Spine Market, Italy, 2005 - 2015 (€)
- Figure 5-253: Synthetic Spine Market, Italy, 2005 - 2015 (US$)
- Figure 5-254: Allograft Cervical Spine Market, Italy, 2005 - 2015 (€)
- Figure 5-255: Allograft Cervical Spine Market, Italy, 2005 - 2015 (US$)
- Figure 5-256: DBM Cervical Spine Market, Italy, 2005 - 2015 (€)
- Figure 5-257: DBM Cervical Spine Market, Italy, 2005 - 2015 (US$)
- Figure 5-258: Synthetic Cervical Spine Market, Italy, 2005 - 2015 (€)
- Figure 5-259: Synthetic Cervical Spine Market, Italy, 2005 - 2015 (US$)
- Figure 5-260: Allograft Thoracolumbar Spine Market, Italy, 2005 - 2015 (€)
- Figure 5-261: Allograft Thoracolumbar Spine Market, Italy, 2005 - 2015 (US$) 240
- Figure 5-262: DBM Thoracolumbar Spine Market, Italy, 2005 - 2015 (€)
- Figure 5-263: DBM Thoracolumbar Spine Market, Italy, 2005 - 2015 (US$)
- Figure 5-264: Synthetic Thoracolumbar Spine Market, Italy, 2005 - 2015 (€)
- Figure 5-265: Synthetic Thoracolumbar Spine Market, Italy, 2005 - 2015 (US$)242
- Figure 5-266: Allograft Extremity Market, Italy, 2005 - 2015 (€)
- Figure 5-267: Allograft Extremity Market, Italy, 2005 - 2015 (US$)
- Figure 5-268: DBM Extremity Market, Italy, 2005 - 2015 (€)
- Figure 5-269: DBM Extremity Market, Italy, 2005 - 2015 (US$)
- Figure 5-270: Synthetic Extremity Market, Italy, 2005 - 2015 (€)
- Figure 5-271: Synthetic Extremity Market, Italy, 2005 - 2015 (US$)
- Figure 5-272: Allograft CMF Market, Italy, 2005 - 2015 (€)
- Figure 5-273: Allograft CMF Market, Italy, 2005 - 2015 (US$)
- Figure 5-274: DBM CMF Market, Italy, 2005 - 2015 (€)
- Figure 5-275: DBM CMF Market, Italy, 2005 - 2015 (US$)
- Figure 5-276: Synthetic CMF Market, Italy, 2005 - 2015 (€)
- Figure 5-277: Synthetic CMF Market, Italy, 2005 - 2015 (US$)
- Figure 5-278: Market Drivers and Limiters, Italy, Bone Graft Substitute Market, 2005 - 2015
- Figure 5-279: Total Autograft Procedures, Benelux, 2005 - 2015
- Figure 5-280 Spine Fusion Procedures, Benelux, 2005 - 2015
- Figure 5-281: Total Bone Graft Substitute Market, Benelux, 2005 - 2015 (€)
- Figure 5-282: Total Bone Graft Substitute Market, Benelux, 2005 - 2015 (US$) 255
- Figure 5-283 Total Procedures by Indication, Benelux, 2005 - 2015
- Figure 5-284 Total Utilized Market Value by Indication, Benelux, 2005 - 2015 (€)
- Figure 5-285 Total Utilized Market Value by Indication, Benelux, 2005 - 2015 (US$)
- Figure 5-286: Utilized Bone Graft Substitute Market, Benelux, 2005 - 2015 (€) 258
- Figure 5-287: Utilized Bone Graft Substitute Market, Benelux, 2005 - 2015 (US$)
- Figure 5-288: Total Allograft Market, Benelux, 2005 - 2015 (€)
- Figure 5-289: Total Allograft Market, Benelux, 2005 - 2015 (US$)
- Figure 5-290: Total DBM Market, Benelux, 2005 - 2015 (€)
- Figure 5-291: Total DBM Market, Benelux, 2005 - 2015 (US$)
- Figure 5-292: Total Synthetic Market, Benelux, 2005 - 2015 (€)
- Figure 5-293: Total Synthetic Market, Benelux, 2005 - 2015 (US$)
- Figure 5-294: Allograft Spine Market, Benelux, 2005 - 2015 (€)
- Figure 5-295: Allograft Spine Market, Benelux, 2005 - 2015 (US$)
- Figure 5-296: DBM Spine Market, Benelux, 2005 - 2015 (€)
- Figure 5-297: DBM Spine Market, Benelux, 2005 - 2015 (US$)
- Figure 5-298: Synthetic Spine Market, Benelux, 2005 - 2015 (€)
- Figure 5-299: Synthetic Spine Market, Benelux, 2005 - 2015 (US$)
- Figure 5-300: Allograft Cervical Spine Market, Benelux, 2005 - 2015 (€)
- Figure 5-301: Allograft Cervical Spine Market, Benelux, 2005 - 2015 (US$)
- Figure 5-302: DBM Cervical Spine Market, Benelux, 2005 - 2015 (€)
- Figure 5-303: DBM Cervical Spine Market, Benelux, 2005 - 2015 (US$)
- Figure 5-304: Synthetic Cervical Spine Market, Benelux, 2005 - 2015 (€)
- Figure 5-305: Synthetic Cervical Spine Market, Benelux, 2005 - 2015 (US$)
- Figure 5-306: Allograft Thoracolumbar Spine Market, Benelux, 2005 - 2015 (€)272
- Figure 5-307: Allograft Thoracolumbar Spine Market, Benelux, 2005 - 2015 (US$)
- Figure 5-308: DBM Thoracolumbar Spine Market, Benelux, 2005 - 2015 (€)
- Figure 5-309: DBM Thoracolumbar Spine Market, Benelux, 2005 - 2015 (US$) 273
- Figure 5-310: Synthetic Thoracolumbar Spine Market, Benelux, 2005 - 2015 (€)274
- Figure 5-311: Synthetic Thoracolumbar Spine Market, Benelux, 2005 - 2015 (US$)
- Figure 5-312: Allograft Extremity Market, Benelux, 2005 - 2015 (€)
- Figure 5-313: Allograft Extremity Market, Benelux, 2005 - 2015 (US$)
- Figure 5-314: DBM Extremity Market, Benelux, 2005 - 2015 (€)
- Figure 5-315: DBM Extremity Market, Benelux, 2005 - 2015 (US$)
- Figure 5-316: Synthetic Extremity Market, Benelux, 2005 - 2015 (€)
- Figure 5-317: Synthetic Extremity Market, Benelux, 2005 - 2015 (US$)
- Figure 5-318: Allograft CMF Market, Benelux, 2005 - 2015 (€)
- Figure 5-319: Allograft CMF Market, Benelux, 2005 - 2015 (US$)
- Figure 5-320: DBM CMF Market, Benelux, 2005 - 2015 (€)
- Figure 5-321: DBM CMF Market, Benelux, 2005 - 2015 (US$)
- Figure 5-322: Synthetic CMF Market, Benelux, 2005 - 2015 (€)
- Figure 5-323: Synthetic CMF Market, Benelux, 2005 - 2015 (US$)
- Figure 5-324: Market Drivers and Limiters, Benelux, Bone Graft Substitute Market, 2005 - 2015
- Figure 5-325: Total Autograft Procedures, Scandinavia, 2005 - 2015
- Figure 5-326 Spine Fusion Procedures, Scandinavia, 2005 - 2015
- Figure 5-327: Total Bone Graft Substitute Market, Scandinavia, 2005 - 2015 (€)287
- Figure 5-328: Total Bone Graft Substitute Market, Scandinavia, 2005 - 2015 (US$)
- Figure 5-329 Total Procedures by Indication, Scandinavia, 2005 - 2015
- Figure 5-330 Total Utilized Market Value by Indication, Scandinavia, 2005 - 2015 (€)
- Figure 5-331 Total Utilized Market Value by Indication, Scandinavia, 2005 - 2015 (US$)
- Figure 5-332: Utilized Bone Graft Substitute Market, Scandinavia, 2005 - 2015 (€)
- Figure 5-333: Utilized Bone Graft Substitute Market, Scandinavia, 2005 - 2015 (US$)
- Figure 5-334: Total Allograft Market, Scandinavia, 2005 - 2015 (€)
- Figure 5-335: Total Allograft Market, Scandinavia, 2005 - 2015 (US$)
- Figure 5-336: Total DBM Market, Scandinavia, 2005 - 2015 (€)
- Figure 5-337: Total DBM Market, Scandinavia, 2005 - 2015 (US$)
- Figure 5-338: Total Synthetic Market, Scandinavia, 2005 - 2015 (€)
- Figure 5-339: Total Synthetic Market, Scandinavia, 2005 - 2015 (US$)
- Figure 5-340: Allograft Spine Market, Scandinavia, 2005 - 2015 (€)
- Figure 5-341: Allograft Spine Market, Scandinavia, 2005 - 2015 (US$)
- Figure 5-342: DBM Spine Market, Scandinavia, 2005 - 2015 (€)
- Figure 5-343: DBM Spine Market, Scandinavia, 2005 - 2015 (US$)
- Figure 5-344: Synthetic Spine Market, Scandinavia, 2005 - 2015 (€)
- Figure 5-345: Synthetic Spine Market, Scandinavia, 2005 - 2015 (US$)
- Figure 5-346: Allograft Cervical Spine Market, Scandinavia, 2005 - 2015 (€)
- Figure 5-347: Allograft Cervical Spine Market, Scandinavia, 2005 - 2015 (US$)300
- Figure 5-348: DBM Cervical Spine Market, Scandinavia, 2005 - 2015 (€)
- Figure 5-349: DBM Cervical Spine Market, Scandinavia, 2005 - 2015 (US$)
- Figure 5-350: Synthetic Cervical Spine Market, Scandinavia, 2005 - 2015 (€)
- Figure 5-351: Synthetic Cervical Spine Market, Scandinavia, 2005 - 2015 (US$)302
- Figure 5-352: Allograft Thoracolumbar Spine Market, Scandinavia, 2005 - 2015 (€)
- Figure 5-353: Allograft Thoracolumbar Spine Market, Scandinavia, 2005 - 2015 (US$)
- Figure 5-354: DBM Thoracolumbar Spine Market, Scandinavia, 2005 - 2015 (€)305
- Figure 5-355: DBM Thoracolumbar Spine Market, Scandinavia, 2005 - 2015 (US$)
- Figure 5-356: Synthetic Thoracolumbar Spine Market, Scandinavia, 2005 - 2015 (€)
- Figure 5-357: Synthetic Thoracolumbar Spine Market, Scandinavia, 2005 - 2015 (US$)
- Figure 5-358: Allograft Extremity Market, Scandinavia, 2005 - 2015 (€)
- Figure 5-359: Allograft Extremity Market, Scandinavia, 2005 - 2015 (US$)
- Figure 5-360: DBM Extremity Market, Scandinavia, 2005 - 2015 (€)
- Figure 5-361: DBM Extremity Market, Scandinavia, 2005 - 2015 (US$)
- Figure 5-362: Synthetic Extremity Market, Scandinavia, 2005 - 2015 (€)
- Figure 5-363: Synthetic Extremity Market, Scandinavia, 2005 - 2015 (US$)
- Figure 5-364: Allograft CMF Market, Scandinavia, 2005 - 2015 (€)
- Figure 5-365: Allograft CMF Market, Scandinavia, 2005 - 2015 (US$)
- Figure 5-366: DBM CMF Market, Scandinavia, 2005 - 2015 (€)
- Figure 5-367: DBM CMF Market, Scandinavia, 2005 - 2015 (US$)
- Figure 5-368: Synthetic CMF Market, Scandinavia, 2005 - 2015 (€)
- Figure 5-369: Synthetic CMF Market, Scandinavia, 2005 - 2015 (US$)
- Figure 5-370: Market Drivers and Limiters, Scandinavia, Bone Graft Substitute
- Market, 2005 - 2015
- Figure 5-371: Total Autograft Procedures, Switzerland, 2005 - 2015
- Figure 5-372 Spine Fusion Procedures, Switzerland, 2005 - 2015
- Figure 5-373: Total Bone Graft Substitute Market, Switzerland, 2005 - 2015 (€)320
- Figure 5-374: Total Bone Graft Substitute Market, Switzerland, 2005 - 2015 (US$)
- Figure 5-375 Total Procedures by Indication, Switzerland, 2005 - 2015
- Figure 5-376 Total Utilized Market Value by Indication, Switzerland, 2005 - 2015 (€)
- Figure 5-377 Total Utilized Market Value by Indication, Switzerland, 2005 - 2015 (US$)
- Figure 5-378: Utilized Bone Graft Substitute Market, Switzerland, 2005 - 2015 (€)
- Figure 5-379: Utilized Bone Graft Substitute Market, Switzerland, 2005 - 2015 (US$)
- Figure 5-380: Total Allograft Market, Switzerland, 2005 - 2015 (€)
- Figure 5-381: Total Allograft Market, Switzerland, 2005 - 2015 (US$)
- Figure 5-382: Total DBM Market, Switzerland, 2005 - 2015 (€)
- Figure 5-383: Total DBM Market, Switzerland, 2005 - 2015 (US$)
- Figure 5-384: Total Synthetic Market, Switzerland, 2005 - 2015 (€)
- Figure 5-385: Total Synthetic Market, Switzerland, 2005 - 2015 (US$)
- Figure 5-386: Allograft Spine Market, Switzerland, 2005 - 2015 (€)
- Figure 5-387: Allograft Spine Market, Switzerland, 2005 - 2015 (US$)
- Figure 5-388: DBM Spine Market, Switzerland, 2005 - 2015 (€)
- Figure 5-389: DBM Spine Market, Switzerland, 2005 - 2015 (US$)
- Figure 5-390: Synthetic Spine Market, Switzerland, 2005 - 2015 (€)
- Figure 5-391: Synthetic Spine Market, Switzerland, 2005 - 2015 (US$)
- Figure 5-392: Allograft Cervical Spine Market, Switzerland, 2005 - 2015 (€)
- Figure 5-393: Allograft Cervical Spine Market, Switzerland, 2005 - 2015 (US$)333
- Figure 5-394: DBM Cervical Spine Market, Switzerland, 2005 - 2015 (€)
- Figure 5-395: DBM Cervical Spine Market, Switzerland, 2005 - 2015 (US$)
- Figure 5-396: Synthetic Cervical Spine Market, Switzerland, 2005 - 2015 (€)
- Figure 5-397: Synthetic Cervical Spine Market, Switzerland, 2005 - 2015 (US$)335
- Figure 5-398: Allograft Thoracolumbar Spine Market, Switzerland, 2005 - 2015 (€)
- Figure 5-399: Allograft Thoracolumbar Spine Market, Switzerland, 2005 - 2015 (US$)
- Figure 5-400: DBM Thoracolumbar Spine Market, Switzerland, 2005 - 2015 (€)338
- Figure 5-401: DBM Thoracolumbar Spine Market, Switzerland, 2005 - 2015 (US$)
- Figure 5-402: Synthetic Thoracolumbar Spine Market, Switzerland, 2005 - 2015 (€)
- Figure 5-403: Synthetic Thoracolumbar Spine Market, Switzerland, 2005 - 2015 (US$)
- Figure 5-404: Allograft Extremity Market, Switzerland, 2005 - 2015 (€)
- Figure 5-405: Allograft Extremity Market, Switzerland, 2005 - 2015 (US$)
- Figure 5-406: DBM Extremity Market, Switzerland, 2005 - 2015 (€)
- Figure 5-407: DBM Extremity Market, Switzerland, 2005 - 2015 (US$)
- Figure 5-408: Synthetic Extremity Market, Switzerland, 2005 - 2015 (€)
- Figure 5-409: Synthetic Extremity Market, Switzerland, 2005 - 2015 (US$)
- Figure 5-410: Allograft CMF Market, Switzerland, 2005 - 2015 (€)
- Figure 5-411: Allograft CMF Market, Switzerland, 2005 - 2015 (US$)
- Figure 5-412: DBM CMF Market, Switzerland, 2005 - 2015 (€)
- Figure 5-413: DBM CMF Market, Switzerland, 2005 - 2015 (US$)
- Figure 5-414: Synthetic CMF Market, Switzerland, 2005 - 2015 (€)
- Figure 5-415: Synthetic CMF Market, Switzerland, 2005 - 2015 (US$)
- Figure 5-416: Market Drivers and Limiters, Switzerland, Bone Graft Substitute Market, 2005 - 2015
- Figure 5-417: Total Autograft Procedures, Austria, 2005 - 2015
- Figure 5-418 Spine Fusion Procedures, Austria, 2005 - 2015
- Figure 5-419: Total Bone Graft Substitute Market, Austria, 2005 - 2015 (€)
- Figure 5-420: Total Bone Graft Substitute Market, Austria, 2005 - 2015 (US$) . 352
- Figure 5-421 Total Procedures by Indication, Austria, 2005 - 2015
- Figure 5-422 Total Utilized Market Value by Indication, Austria, 2005 - 2015 (€)354
- Figure 5-423 Total Utilized Market Value by Indication, Austria, 2005 - 2015 (US$)
- Figure 5-424: Utilized Bone Graft Substitute Market, Austria, 2005 - 2015 (€) . 355
- Figure 5-425: Utilized Bone Graft Substitute Market, Austria, 2005 - 2015 (US$)355
- Figure 5-426: Total Allograft Market, Austria, 2005 - 2015 (€)
- Figure 5-427: Total Allograft Market, Austria, 2005 - 2015 (US$)
- Figure 5-428: Total DBM Market, Austria, 2005 - 2015 (€)
- Figure 5-429: Total DBM Market, Austria, 2005 - 2015 (US$)
- Figure 5-430: Total Synthetic Market, Austria, 2005 - 2015 (€)
- Figure 5-431: Total Synthetic Market, Austria, 2005 - 2015 (US$)
- Figure 5-432: Allograft Spine Market, Austria, 2005 - 2015 (€)
- Figure 5-433: Allograft Spine Market, Austria, 2005 - 2015 (US$)
- Figure 5-434: DBM Spine Market, Austria, 2005 - 2015 (€)
- Figure 5-435: DBM Spine Market, Austria, 2005 - 2015 (US$)
- Figure 5-436: Synthetic Spine Market, Austria, 2005 - 2015 (€)
- Figure 5-437: Synthetic Spine Market, Austria, 2005 - 2015 (US$)
- Figure 5-438: Allograft Cervical Spine Market, Austria, 2005 - 2015 (€)
- Figure 5-439: Allograft Cervical Spine Market, Austria, 2005 - 2015 (US$)
- Figure 5-440: DBM Cervical Spine Market, Austria, 2005 - 2015 (€)
- Figure 5-441: DBM Cervical Spine Market, Austria, 2005 - 2015 (US$)
- Figure 5-442: Synthetic Cervical Spine Market, Austria, 2005 - 2015 (€)
- Figure 5-443: Synthetic Cervical Spine Market, Austria, 2005 - 2015 (US$)
- Figure 5-444: Allograft Thoracolumbar Spine Market, Austria, 2005 - 2015 (€) 369
- Figure 5-445: Allograft Thoracolumbar Spine Market, Austria, 2005 - 2015 (US$)
- Figure 5-446: DBM Thoracolumbar Spine Market, Austria, 2005 - 2015 (€)
- Figure 5-447: DBM Thoracolumbar Spine Market, Austria, 2005 - 2015 (US$) . 370
- Figure 5-448: Synthetic Thoracolumbar Spine Market, Austria, 2005 - 2015 (€) 371
- Figure 5-449: Synthetic Thoracolumbar Spine Market, Austria, 2005 - 2015 (US$)
- Figure 5-450: Allograft Extremity Market, Austria, 2005 - 2015 (€)
- Figure 5-451: Allograft Extremity Market, Austria, 2005 - 2015 (US$)
- Figure 5-452: DBM Extremity Market, Austria, 2005 - 2015 (€)
- Figure 5-453: DBM Extremity Market, Austria, 2005 - 2015 (US$)
- Figure 5-454: Synthetic Extremity Market, Austria, 2005 - 2015 (€)
- Figure 5-455: Synthetic Extremity Market, Austria, 2005 - 2015 (US$)
- Figure 5-456: Allograft CMF Market, Austria, 2005 - 2015 (€)
- Figure 5-457: Allograft CMF Market, Austria, 2005 - 2015 (US$)
- Figure 5-458: DBM CMF Market, Austria, 2005 - 2015 (€)
- Figure 5-459: DBM CMF Market, Austria, 2005 - 2015 (US$)
- Figure 5-460: Synthetic CMF Market, Austria, 2005 - 2015 (€)
- Figure 5-461: Synthetic CMF Market, Austria, 2005 - 2015 (US$)
- Figure 5-462: Market Drivers and Limiters, Austria, Bone Graft Substitute Market, 2005 - 2015
- Figure 5-463: Total Autograft Procedures, Portugal, 2005 - 2015
- Figure 5-464 Spine Fusion Procedures, Portugal, 2005 - 2015
- Figure 5-465: Total Bone Graft Substitute Market, Portugal, 2005 - 2015 (€)
- Figure 5-466: Total Bone Graft Substitute Market, Portugal, 2005 - 2015 (US$) 384
- Figure 5-467 Total Procedures by Indication, Portugal, 2005 - 2015
- Figure 5-468 Total Utilized Market Value by Indication, Portugal, 2005 - 2015 (€)
- Figure 5-469 Total Utilized Market Value by Indication, Portugal, 2005 - 2015 (US$)
- Figure 5-470: Utilized Bone Graft Substitute Market, Portugal, 2005 - 2015 (€) 387
- Figure 5-471: Utilized Bone Graft Substitute Market, Portugal, 2005 - 2015 (US$)
- Figure 5-472: Total Allograft Market, Portugal, 2005 - 2015 (€)
- Figure 5-473: Total Allograft Market, Portugal, 2005 - 2015 (US$)
- Figure 5-474: Total DBM Market, Portugal, 2005 - 2015 (€)
- Figure 5-475: Total DBM Market, Portugal, 2005 - 2015 (US$)
- Figure 5-476: Total Synthetic Market, Portugal, 2005 - 2015 (€)
- Figure 5-477: Total Synthetic Market, Portugal, 2005 - 2015 (US$)
- Figure 5-478: Allograft Spine Market, Portugal, 2005 - 2015 (€)
- Figure 5-479: Allograft Spine Market, Portugal, 2005 - 2015 (US$)
- Figure 5-480: DBM Spine Market, Portugal, 2005 - 2015 (€)
- Figure 5-481: DBM Spine Market, Portugal, 2005 - 2015 (US$)
- Figure 5-482: Synthetic Spine Market, Portugal, 2005 - 2015 (€)
- Figure 5-483: Synthetic Spine Market, Portugal, 2005 - 2015 (US$)
- Figure 5-484: Allograft Cervical Spine Market, Portugal, 2005 - 2015 (€)
- Figure 5-485: Allograft Cervical Spine Market, Portugal, 2005 - 2015 (US$)
- Figure 5-486: DBM Cervical Spine Market, Portugal, 2005 - 2015 (€)
- Figure 5-487: DBM Cervical Spine Market, Portugal, 2005 - 2015 (US$)
- Figure 5-488: Synthetic Cervical Spine Market, Portugal, 2005 - 2015 (€)
- Figure 5-489: Synthetic Cervical Spine Market, Portugal, 2005 - 2015 (US$)
- Figure 5-490: Allograft Thoracolumbar Spine Market, Portugal, 2005 - 2015 (€)401
- Figure 5-491: Allograft Thoracolumbar Spine Market, Portugal, 2005 - 2015 (US$)
- Figure 5-492: DBM Thoracolumbar Spine Market, Portugal, 2005 - 2015 (€)
- Figure 5-493: DBM Thoracolumbar Spine Market, Portugal, 2005 - 2015 (US$) 402
- Figure 5-494: Synthetic Thoracolumbar Spine Market, Portugal, 2005 - 2015 (€)403
- Figure 5-495: Synthetic Thoracolumbar Spine Market, Portugal, 2005 - 2015 (US$)
- Figure 5-496: Allograft Extremity Market, Portugal, 2005 - 2015 (€)
- Figure 5-497: Allograft Extremity Market, Portugal, 2005 - 2015 (US$)
- Figure 5-498: DBM Extremity Market, Portugal, 2005 - 2015 (€)
- Figure 5-499: DBM Extremity Market, Portugal, 2005 - 2015 (US$)
- Figure 5-500: Synthetic Extremity Market, Portugal, 2005 - 2015 (€)
- Figure 5-501: Synthetic Extremity Market, Portugal, 2005 - 2015 (US$)
- Figure 5-502: Allograft CMF Market, Portugal, 2005 - 2015 (€)
- Figure 5-503: Allograft CMF Market, Portugal, 2005 - 2015 (US$)
- Figure 5-504: DBM CMF Market, Portugal, 2005 - 2015 (€)
- Figure 5-505: DBM CMF Market, Portugal, 2005 - 2015 (US$)
- Figure 5-506: Synthetic CMF Market, Portugal, 2005 - 2015 (€)
- Figure 5-507: Synthetic CMF Market, Portugal, 2005 - 2015 (US$)
- Figure 5-508: Market Drivers and Limiters, Portugal, Bone Graft Substitute Market, 2005 - 2015
- Figure 5-509: Total Autograft Procedures, Greece, 2005 - 2015
- Figure 5-510 Spine Fusion Procedures, Greece, 2005 - 2015
- Figure 5-511: Total Bone Graft Substitute Market, Greece, 2005 - 2015 (€)
- Figure 5-512: Total Bone Graft Substitute Market, Greece, 2005 - 2015 (US$) . 416
- Figure 5-513 Total Procedures by Indication, Greece, 2005 - 2015
- Figure 5-514 Total Utilized Market Value by Indication, Greece, 2005 - 2015 (€)418
- Figure 5-515 Total Utilized Market Value by Indication, Greece, 2005 - 2015 (US$)
- Figure 5-516: Utilized Bone Graft Substitute Market, Greece, 2005 - 2015 (€)
- Figure 5-517: Utilized Bone Graft Substitute Market, Greece, 2005 - 2015 (US$)419
- Figure 5-518: Total Allograft Market, Greece, 2005 - 2015 (€)
- Figure 5-519: Total Allograft Market, Greece, 2005 - 2015 (US$)
- Figure 5-520: Total DBM Market, Greece, 2005 - 2015 (€)
- Figure 5-521: Total DBM Market, Greece, 2005 - 2015 (US$)
- Figure 5-522: Total Synthetic Market, Greece, 2005 - 2015 (€)
- Figure 5-523: Total Synthetic Market, Greece, 2005 - 2015 (US$)
- Figure 5-524: Allograft Spine Market, Greece, 2005 - 2015 (€)
- Figure 5-525: Allograft Spine Market, Greece, 2005 - 2015 (US$)
- Figure 5-526: DBM Spine Market, Greece, 2005 - 2015 (€)
- Figure 5-527: DBM Spine Market, Greece, 2005 - 2015 (US$)
- Figure 5-528: Synthetic Spine Market, Greece, 2005 - 2015 (€)
- Figure 5-529: Synthetic Spine Market, Greece, 2005 - 2015 (US$)
- Figure 5-530: Allograft Cervical Spine Market, Greece, 2005 - 2015 (€)
- Figure 5-531: Allograft Cervical Spine Market, Greece, 2005 - 2015 (US$)
- Figure 5-532: DBM Cervical Spine Market, Greece, 2005 - 2015 (€)
- Figure 5-533: DBM Cervical Spine Market, Greece, 2005 - 2015 (US$)
- Figure 5-534: Synthetic Cervical Spine Market, Greece, 2005 - 2015 (€)
- Figure 5-535: Synthetic Cervical Spine Market, Greece, 2005 - 2015 (US$)
- Figure 5-536: Allograft Thoracolumbar Spine Market, Greece, 2005 - 2015 (€) 433
- Figure 5-537: Allograft Thoracolumbar Spine Market, Greece, 2005 - 2015 (US$)
- Figure 5-538: DBM Thoracolumbar Spine Market, Greece, 2005 - 2015 (€)
- Figure 5-539: DBM Thoracolumbar Spine Market, Greece, 2005 - 2015 (US$) . 434
- Figure 5-540: Synthetic Thoracolumbar Spine Market, Greece, 2005 - 2015 (€) 435
- Figure 5-541: Synthetic Thoracolumbar Spine Market, Greece, 2005 - 2015 (US$)
- Figure 5-542: Allograft Extremity Market, Greece, 2005 - 2015 (€)
- Figure 5-543: Allograft Extremity Market, Greece, 2005 - 2015 (US$)
- Figure 5-544: DBM Extremity Market, Greece, 2005 - 2015 (€)
- Figure 5-545: DBM Extremity Market, Greece, 2005 - 2015 (US$)
- Figure 5-546: Synthetic Extremity Market, Greece, 2005 - 2015 (€)
- Figure 5-547: Synthetic Extremity Market, Greece, 2005 - 2015 (US$)
- Figure 5-548: Allograft CMF Market, Greece, 2005 - 2015 (€)
- Figure 5-549: Allograft CMF Market, Greece, 2005 - 2015 (US$)
- Figure 5-550: DBM CMF Market, Greece, 2005 - 2015 (€)
- Figure 5-551: DBM CMF Market, Greece, 2005 - 2015 (US$)
- Figure 5-552: Synthetic CMF Market, Greece, 2005 - 2015 (€)
- Figure 5-553: Synthetic CMF Market, Greece, 2005 - 2015 (US$)
- Figure 5-554: Market Drivers and Limiters, Greece, Bone Graft Substitute Market, 2005 - 2015
- BMP GROWTH FACTOR MARKET
- Figure 6-1: Orthopedic Growth Factor Market, Europe, 2005 - 2015 (€)
- Figure 6-2: Orthopedic Growth Factor Market, Europe, 2005 - 2015 ($US)
- Figure 6-3: Drivers and Limiters, Orthopedic Growth Factor Market, Europe, 2005 - 2015
- Figure 6-4: Leading Competitors, Orthopedic Growth Factor Market, Europe, 2008
- HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
- Figure 7-1: Total Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 (€)
- Figure 7-2: Total Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 ($US)
- Figure 7-3: Single-Cycle Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 (€)
- Figure 7-4: Single-Cycle Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 ($US)
- Figure 7-5: Three-Cycle Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 (€)
- Figure 7-6: Three-Cycle Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 ($US)
- Figure 7-7: Five-Cycle Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 (€)
- Figure 7-8: Five-Cycle Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 ($US)
- Figure 7-9: Hyaluronic Acid Viscosupplementation Injections per Country, Europe, 2008
- Figure 7-10: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015
- Figure 7-11: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Europe, 2008
- AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET
- Figure 8-1: ACI Market, Europe, 2005 - 2015 (€)
- Figure 8-2: ACI Market, Europe, 2005 - 2015 ($US)
- Figure 8-3: Drivers and Limiters, ACI Market, Europe, 2005 - 2015
- Figure 8-4: Leading Competitors, Autologous Chondrocyte Implantation Market, Europe, 2008
- Figure 8-5: Leading Competitors, Autologous Chondrocyte Implantation Market, Europe, 2008
- PLATELET AND BONE MARROW CONCENTRATION MARKET
- Figure 9-1: Total Cell Concentration Market, Europe, 2005 - 2015 (€)
- Figure 9-2: Total Cell Concentration Market, Europe, 2005 - 2015 (€)
- Figure 9-3: Total Cell Concentration Market, Europe, 2005 - 2015 ($US)
- Figure 9-4: Platelet Concentration Market, Europe, 2005 - 2015 (€)
- Figure 9-5: Platelet Concentration Market, Europe, 2005 - 2015 ($US)
- Figure 9-6: Bone Marrow Concentration Market, Europe, 2005 - 2015 (€)
- Figure 9-7: Bone Marrow Concentration Market, Europe, 2005 - 2015 ($US)
- Figure 9-8: Drivers and Limiters, Platelet and Bone Marrow Concentration Market, Europe, 2005 - 2015
- Figure 9-9: Leading Competitors, Platelet and Bone Marrow Concentration Market, Europe, 2008
- ABBREVIATIONS
- APPENDIX 1: JOINT RECONSTRUCTION PROCEDURES
- Figure 11-1: Combined Joint Revision Procedures, Europe, 2005 - 2015
- Figure 11-2: Hip Joint Revision Procedures, Europe, 2005 - 2015
- Figure 11-3: Knee Joint Revision Procedures, Europe, 2005 - 2015
- LIST OF CHARTS
- EXECUTIVE SUMMARY
- Chart 1-1: Total Biomaterial Market, Europe, 2005 - 2015 (€)
- Chart 1-2: Autograft Procedures, Europe, 2008
- Chart 1-3: BGS Units, Used and Unused, Europe, 2005 - 2015
- Chart 1-4: Units Implanted, Bone Graft Substitute Market, Europe, 2008
- Chart 1-5: Hyaluronic Viscosupplementation Procedures, Europe, 2005 - 2015
- Chart 1-6: Autologous Chondrocyte Implantation Market, Europe, 2005 - 2015 (€)
- Chart 1-7: Leading Competitors, Orthopedic Biomaterial Market, Europe, 2008
- RESEARCH METHODOLOGY
- OVERVIEW OF EUROPEAN ORTHOPEDIC BIOMATERIALS
- Chart 3-1: Total European Orthopedic Biomaterial Market, Europe, 2005 - 2015 (€)
- Chart 3-2: Total European Orthopedic Biomaterial Market by Segment, Europe, 2008
- Chart 3-3: Leading Competitors, Orthopedic Biomaterials Market, Europe, 2008
- COUNTRY PROFILES
- Chart 4-1: German Price Index, GDP per Capita, and Population, 2008
- Chart 4-2: French Price Index, GDP per Capita, and Population, 2008
- Chart 4-3: U.K. Price Index, GDP per Capita, and Population, 2008
- Chart 4-4: Spanish Price Index, GDP per Capita, and Population, 2008
- Chart 4-5: Italian Price Index, GDP per Capita, and Population, 2008
- Chart 4-6: Beneluxian Price Index, GDP per Capita, and Population, 2008
- Chart 4-7: Scandinavian Price Index, GDP per Capita, and Population, 2008
- Chart 4-8: Swiss Price Index, GDP per Capita, and Population, 2008
- Chart 4-9: Austrian Price Index, GDP per Capita, and Population, 2008
- Chart 4-10: Portuguese Price Index, GDP per Capita, and Population, 2008
- Chart 4-11: Greek Price Index, GDP per Capita, and Population, 2008
- Chart 4-12: Bone Graft Substitute Procedures per Population, Europe, 2008
- BONE GRAFT SUBSTITUTE MARKET
- Chart 5-1: Total Bone Graft Substitute Market, Europe, 2005 - 2015 (€)
- Chart 5-2: Total Market Value by Country, Europe, 2008 (€)
- Chart 5-3: Total Bone Graft Substitute Procedures by Country, Europe, 2008 (€) 57
- Chart 5-4: Total Bone Graft Substitute Market, Germany, 2005 - 2015 (€)
- Chart 5-5: Total Bone Graft Substitute Market, France, 2005 - 2015 (€)
- Chart 5-6: Total Bone Graft Substitute Market, U.K., 2005 - 2015 (€)
- Chart 5-7: Total Bone Graft Substitute Market, Spain, 2005 - 2015 (€)
- Chart 5-8: Total Bone Graft Substitute Market, Italy, 2005 - 2015 (€)
- Chart 5-9: Total Bone Graft Substitute Market, Benelux, 2005 - 2015 (€)
- Chart 5-10: Total Bone Graft Substitute Market, Scandinavia, 2005 - 2015 (€)
- Chart 5-11: Total Bone Graft Substitute Market, Switzerland, 2005 - 2015 (€)
- Chart 5-12: Total Bone Graft Substitute Market, Austria, 2005 - 2015 (€)
- Chart 5-13: Total Bone Graft Substitute Market, Portugal, 2005 - 2015 (€)
- Chart 5-14: Total Bone Graft Substitute Market, Greece, 2005 - 2015 (€)
- BMP GROWTH FACTOR MARKET
- Chart 6-1: Orthopedic Growth Factor Market, Europe, 2005 - 2015 (€)
- Chart 6-2: Leading Competitors, Orthopedic Growth Factor Market, Europe, 2008
- HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
- Chart 7-1: Total Hyaluronic Acid Viscosupplement Market, Europe, 2005 - 2015456
- Chart 7-2: Total Single-Cycle Hyaluronic Acid Viscosupplement Market, Europe, 2005 - 2015
- Chart 7-3: Total Three-Cycle Hyaluronic Acid Viscosupplement Market, Europe, 2005 - 2015
- Chart 7-4: Total Five-Cycle Hyaluronic Acid Viscosupplement Market, Europe, 2005 - 2015
- Chart 7-5 Hyaluronic Acid Viscosupplementation Injections per Country, Europe, 2008
- Chart 7-6: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Europe, 2008
- AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET
- Chart 8-1: ACI Market, Europe, 2005 - 2015 (€)
- PLATELET AND BONE MARROW CONCENTRATION MARKET
- Chart 9-1: Figure 9-1: Total Cell Concentration Market, Europe, 2005 - 2015 (€)481
- Chart 9-2: Platelet Concentration Market, Europe, 2005 - 2015 (€)
- Chart 9-3: Bone Marrow Concentration Market, Europe, 2005 - 2015 (€)
- Chart 9-4: Leading Competitors, Platelet and Bone Marrow Concentration Market, Europe, 2008
- ABBREVIATIONS
- APPENDIX 1: JOINT RECONSTRUCTION PROCEDURES
Related Markets
Orthopedics Reports
- European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries)
- European Markets For Orthopedic Biomaterials 2011
- US Markets for Orthopedic Biomaterials 2011
- U.S. Market for Orthopedic Biomaterials 2010
- Asia Pacific Markets for Orthopedic Biomaterials 2009
